Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1060009/000156459018003936/knd-10k_20171231.htm
July 2018
June 2018
April 2018
February 2018
February 2018
February 2018
December 2017
December 2017
December 2017
November 2017
Exhibit 99.1
Contact: | Todd Flowers | |
Investor Relations (502) 596-6569 |
KINDRED HEALTHCARE REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS
Consolidated Revenues of $1.5 Billion, GAAP Loss from Continuing Operations of $135 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $1.65(1), and EBITDA Loss of $193 Million(2) in the Fourth Quarter
Core EBITDA of $119 Million(3) and Core Diluted Earnings Per Share from Continuing Operations of $0.20(3) in the Fourth Quarter
GAAP and Core Results in the Fourth Quarter include Negative Pretax Earnings Impact of $2 Million and Diluted EPS Impact of $0.02 from LTAC Hospital Closures
Consolidated Revenues of $6.0 Billion, GAAP Loss from Continuing Operations of $247 Million, GAAP Diluted Loss Per Share from Continuing Operations of $3.31, and EBITDA Loss of $62 Million(3) for the Year
Core EBITDA of $444 Million(3) and Core Diluted Earnings Per Share from Continuing Operations of $0.34(3) for the Year
GAAP and Core Results for the Year Include Negative Pretax Earnings Impact of $16 Million from Hurricanes and $6 Million from LTAC Hospital Closures and Diluted EPS Impact of $0.11 from Hurricanes and $0.04 from LTAC Hospital Closures
GAAP Operating Cash Flows of $67 Million in the Fourth Quarter
Core Operating Cash Flows of $87 Million(3) in the Fourth Quarter
GAAP Operating Cash Flows of $76 Million for the Year; Core Operating Cash Flows of $137 Million(3) for the Year
Core Free Cash Flows of $50 Million(3) in the Fourth Quarter; Core Free Cash Flows of $6 Million(3) for the Year
Company Reaffirms 2018 Outlook and Does Not Intend to Provide Future Guidance Updates Due to Pending Merger
LOUISVILLE, Ky. (February 28, 2018) Kindred Healthcare, Inc. (Kindred or the Company) (NYSE:KND) today announced its operating results for the fourth quarter and full year ended December 31, 2017. The Company also today will file its Annual Report on Form 10-K with the Securities and Exchange Commission (SEC).
On December 19, 2017, the Company announced that its Board of Directors approved a definitive agreement under which it will be acquired by a consortium of three companies: TPG Capital (TPG), Welsh, Carson, Anderson & Stowe (WCAS) and Humana Inc. (Humana) (NYSE:HUM) (together, the Consortium) for approximately $4.1 billion in cash including the assumption or repayment of net debt (the Merger). Immediately following the Merger, the home health, hospice and community care businesses will be separated from the Company and operated as a standalone company owned 40 percent by Humana, with the remaining 60 percent owned by TPG and WCAS. The Companys long-term acute care (LTAC) hospitals, inpatient rehabilitation facilities (IRFs) and contract rehabilitation services businesses will be operated as a separate specialty hospital company owned by TPG and WCAS.
Benjamin A. Breier, President and Chief Executive Officer of Kindred, commented, Our fourth quarter results reflect continued execution of the Companys strategy. We are pleased to be moving forward with the Consortium and look forward to completing the Merger to deliver immediate and certain value to Kindred stockholders at a substantial premium and eliminate the significant risks associated with continuing to operate as a standalone public company or pursuing other strategic alternatives. We are confident that the Merger will enhance innovation at both the home care and specialty hospital companies, further Kindreds culture of a patient-first approach to care and create new opportunities for Kindred employees.
(1) | Results reflect after-tax costs of $163.7 million or $1.86 per diluted share related to impairment charges, insurance restructuring costs, other restructuring charges, litigation contingency expense, net change in deferred tax asset valuation allowance and an adjustment to reduce deferred tax liabilities based upon certain changes enacted by the Tax Cuts and Jobs Act of 2017 (the Tax Reform Act). |
(2) | Results reflect pretax costs of $312.0 million related to impairment charges, insurance restructuring costs, other restructuring charges and litigation contingency expense. As used herein, EBITDA means earnings before interest, income taxes, depreciation and amortization. See reconciliation of generally accepted accounting principles (GAAP) results to non-GAAP results beginning on page 14. |
(3) | See reconciliation of GAAP results to non-GAAP results beginning on page 14. During the first quarter of 2017, the Company revised its definition of core non-GAAP measures. See Non-GAAP Measures beginning on page 14 for a discussion regarding the revised definitions. For comparability, core results for 2016 were revised to conform to the current year presentation. |
MORE
680 South Fourth Street Louisville, Kentucky 40202
502.596.7300 www.kindredhealthcare.com
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1060009/000156459018003936/knd-10k_20171231.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Kindred Healthcare, Inc.
Kindred Healthcare, Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Kindred Healthcare, Inc provided additional information to their SEC Filing as exhibits
Ticker: KND
CIK: 1060009
Form Type: 10-K Annual Report
Accession Number: 0001564590-18-003936
Submitted to the SEC: Wed Feb 28 2018 9:55:00 PM EST
Accepted by the SEC: Thu Mar 01 2018
Period: Sunday, December 31, 2017
Industry: Nursing And Personal Care Facilities